NCT06672094View on ClinicalTrials.gov

A Study to Investigate the Safety and Efficacy of NeuroQ on Cognitive Function in Health Adults with Self-Reported Memory Problems

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

July 23, 2024

Study Completion Date

July 23, 2024

Conditions
HealthySelf-reported Memory Problems
Interventions
DIETARY_SUPPLEMENT

NeuroQ

Two (2) capsules of NeuroQ taken once a day for 60 days.

OTHER

Placebo

Two (2) capsules of placebo taken once a day for 60 days.

Trial Locations (1)

N6B 3L1

KGK Science Inc., London

All Listed Sponsors
lead

LifeSeasons Inc.

INDUSTRY

NCT06672094 - A Study to Investigate the Safety and Efficacy of NeuroQ on Cognitive Function in Health Adults with Self-Reported Memory Problems | Biotech Hunter | Biotech Hunter